Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 5.09
+0.05 (0.89%)
Sep 30, 2026, 4:08 PM HKT
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 4.15 billion as of October 1, 2026. Its market cap has decreased by -38.88% in one year.
Market Cap
4.15B
Enterprise Value
3.87B
Revenue
1.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
5.09
ChartMarket Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 4.15B, a decrease of -80.52%. That is a compound annual growth rate of -23.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 4.15B | -31.28% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CK Life Sciences Int'l., (Holdings) | 5.24B |
| Jacobio Pharmaceuticals Group | 4.75B |
| TransThera Sciences (Nanjing) | 4.46B |
| Shanghai Bao Pharmaceuticals | 4.01B |
| Hanx Biopharmaceuticals (Wuhan) | 3.95B |
| Qyuns Therapeutics | 3.79B |
| Mirxes Holding Company | 3.66B |
| Laekna | 3.50B |